Table of Contents

1 Mifepristone API Market Overview

• 1.1 Product Overview and Scope of Mifepristone API
• 1.2 Mifepristone API Segment by Type
  • 1.2.1 Global Mifepristone API Market Size Growth Rate Analysis by Type 2022 VS 2028
  • 1.2.2 Purity ≥98%
  • 1.2.3 Purity ≥99%
• 1.3 Mifepristone API Segment by Application
  • 1.3.1 Global Mifepristone API Consumption Comparison by Application: 2022 VS 2028
  • 1.3.2 Tablet
  • 1.3.3 Capsule
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Mifepristone API Revenue Estimates and Forecasts (2017-2028)
  • 1.4.2 Global Mifepristone API Production Capacity Estimates and Forecasts (2017-2028)
  • 1.4.3 Global Mifepristone API Production Estimates and Forecasts (2017-2028)
• 1.5 Global Market Size by Region
  • 1.5.1 Global Mifepristone API Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
  • 1.5.2 North America Mifepristone API Estimates and Forecasts (2017-2028)
  • 1.5.3 Europe Mifepristone API Estimates and Forecasts (2017-2028)
  • 1.5.4 China Mifepristone API Estimates and Forecasts (2017-2028)
  • 1.5.5 Japan Mifepristone API Estimates and Forecasts (2017-2028)

2 Market Competition by Manufacturers

• 2.1 Global Mifepristone API Production Capacity Market Share by Manufacturers (2017-2022)
• 2.2 Global Mifepristone API Revenue Market Share by Manufacturers (2017-2022)
• 2.3 Mifepristone API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.4 Global Mifepristone API Average Price by Manufacturers (2017-2022)
• 2.5 Manufacturers Mifepristone API Production Sites, Area Served, Product Types
• 2.6 Mifepristone API Market Competitive Situation and Trends
  • 2.6.1 Mifepristone API Market Concentration Rate
  • 2.6.2 Global 5 and 10 Largest Mifepristone API Players Market Share by Revenue
  • 2.6.3 Mergers & Acquisitions, Expansion

3 Production Capacity by Region

• 3.1 Global Production Capacity of Mifepristone API Market Share by Region (2017-2022)
• 3.2 Global Mifepristone API Revenue Market Share by Region (2017-2022)
• 3.3 Global Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
• 3.4 North America Mifepristone API Production
  • 3.4.1 North America Mifepristone API Production Growth Rate (2017-2022)
  • 3.4.2 North America Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
• 3.5 Europe Mifepristone API Production
  • 3.5.1 Europe Mifepristone API Production Growth Rate (2017-2022)
  • 3.5.2 Europe Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
• 3.6 China Mifepristone API Production
  • 3.6.1 China Mifepristone API Production Growth Rate (2017-2022)
  • 3.6.2 China Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
• 3.7 Japan Mifepristone API Production
  • 3.7.1 Japan Mifepristone API Production Growth Rate (2017-2022)
  • 3.7.2 Japan Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)

4 Global Mifepristone API Consumption by Region

• 4.1 Global Mifepristone API Consumption by Region
  • 4.1.1 Global Mifepristone API Consumption by Region
  • 4.1.2 Global Mifepristone API Consumption Market Share by Region
• 4.2 North America
  • 4.2.1 North America Mifepristone API Consumption by Country
  • 4.2.2 United States
  • 4.2.3 Canada
• 4.3 Europe
  • 4.3.1 Europe Mifepristone API Consumption by Country
  • 4.3.2 Germany
  • 4.3.3 France
  • 4.3.4 U.K.
  • 4.3.5 Italy
  • 4.3.6 Russia
• 4.4 Asia Pacific
  • 4.4.1 Asia Pacific Mifepristone API Consumption by Region
  • 4.4.2 China
  • 4.4.3 Japan
  • 4.4.4 South Korea
  • 4.4.5 China Taiwan
  • 4.4.6 Southeast Asia
  • 4.4.7 India
  • 4.4.8 Australia
• 4.5 Latin America
  • 4.5.1 Latin America Mifepristone API Consumption by Country
  • 4.5.2 Mexico
  • 4.5.3 Brazil

5 Segment by Type

• 5.1 Global Mifepristone API Production Market Share by Type (2017-2022)
• 5.2 Global Mifepristone API Revenue Market Share by Type (2017-2022)
• 5.3 Global Mifepristone API Price by Type (2017-2022)

6 Segment by Application

• 6.1 Global Mifepristone API Production Market Share by Application (2017-2022)
• 6.2 Global Mifepristone API Revenue Market Share by Application (2017-2022)
• 6.3 Global Mifepristone API Price by Application (2017-2022)

7 Key Companies Profiled

• 7.1 Xianju Pharmaceutical
  • 7.1.1 Xianju Pharmaceutical Mifepristone API Corporation Information
  • 7.1.2 Xianju Pharmaceutical Mifepristone API Product Portfolio
  • 7.1.3 Xianju Pharmaceutical Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
  • 7.1.4 Xianju Pharmaceutical Main Business and Markets Served
  • 7.1.5 Xianju Pharmaceutical Recent Developments/Updates
• 7.2 Junye Pharma
  • 7.2.1 Junye Pharma Mifepristone API Corporation Information
  • 7.2.2 Junye Pharma Mifepristone API Product Portfolio
  • 7.2.3 Junye Pharma Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
  • 7.2.4 Junye Pharma Main Business and Markets Served
  • 7.2.5 Junye Pharma Recent Developments/Updates
• 7.3 Humanwell Healthcare
  • 7.3.1 Humanwell Healthcare Mifepristone API Corporation Information
  • 7.3.2 Humanwell Healthcare Mifepristone API Product Portfolio
  • 7.3.3 Humanwell Healthcare Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
  • 7.3.4 Humanwell Healthcare Main Business and Markets Served
  • 7.3.5 Humanwell Healthcare Recent Developments/Updates
• 7.4 KEDE Chemical
  • 7.4.1 KEDE Chemical Mifepristone API Corporation Information
  • 7.4.2 KEDE Chemical Mifepristone API Product Portfolio
  • 7.4.3 KEDE Chemical Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
  • 7.4.4 KEDE Chemical Main Business and Markets Served
  • 7.4.5 KEDE Chemical Recent Developments/Updates
• 7.5 Enomark
  • 7.5.1 Enomark Mifepristone API Corporation Information
  • 7.5.2 Enomark Mifepristone API Product Portfolio
  • 7.5.3 Enomark Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
  • 7.5.4 Enomark Main Business and Markets Served
  • 7.5.5 Enomark Recent Developments/Updates
• 7.6 Richon Chem
  • 7.6.1 Richon Chem Mifepristone API Corporation Information
  • 7.6.2 Richon Chem Mifepristone API Product Portfolio
  • 7.6.3 Richon Chem Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
  • 7.6.4 Richon Chem Main Business and Markets Served
  • 7.6.5 Richon Chem Recent Developments/Updates
• 7.7 Aspen
  • 7.7.1 Aspen Mifepristone API Corporation Information
  • 7.7.2 Aspen Mifepristone API Product Portfolio
  • 7.7.3 Aspen Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
  • 7.7.4 Aspen Main Business and Markets Served
  • 7.7.5 Aspen Recent Developments/Updates
• 7.8 Formosa Laboratories
  • 7.8.1 Formosa Laboratories Mifepristone API Corporation Information
  • 7.8.2 Formosa Laboratories Mifepristone API Product Portfolio
  • 7.8.3 Formosa Laboratories Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
  • 7.8.4 Formosa Laboratories Main Business and Markets Served
  • 7.7.5 Formosa Laboratories Recent Developments/Updates
• 7.9 Curia Global
  • 7.9.1 Curia Global Mifepristone API Corporation Information
  • 7.9.2 Curia Global Mifepristone API Product Portfolio
  • 7.9.3 Curia Global Mifepristone API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
  • 7.9.4 Curia Global Main Business and Markets Served
  • 7.9.5 Curia Global Recent Developments/Updates

8 Mifepristone API Manufacturing Cost Analysis

• 8.1 Mifepristone API Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Mifepristone API
• 8.4 Mifepristone API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 Mifepristone API Distributors List
• 9.3 Mifepristone API Customers

10 Market Dynamics

• 10.1 Mifepristone API Industry Trends
• 10.2 Mifepristone API Market Drivers
• 10.3 Mifepristone API Market Challenges
• 10.4 Mifepristone API Market Restraints

11 Production and Supply Forecast

• 11.1 Global Forecasted Production of Mifepristone API by Region (2023-2028)
• 11.2 North America Mifepristone API Production, Revenue Forecast (2023-2028)
• 11.3 Europe Mifepristone API Production, Revenue Forecast (2023-2028)
• 11.4 China Mifepristone API Production, Revenue Forecast (2023-2028)
• 11.5 Japan Mifepristone API Production, Revenue Forecast (2023-2028)

12 Consumption and Demand Forecast

• 12.1 Global Forecasted Demand Analysis of Mifepristone API
• 12.2 North America Forecasted Consumption of Mifepristone API by Country
• 12.3 Europe Market Forecasted Consumption of Mifepristone API by Country
• 12.4 Asia Pacific Market Forecasted Consumption of Mifepristone API by Region
• 12.5 Latin America Forecasted Consumption of Mifepristone API by Country

13 Forecast by Type and by Application (2023-2028)

• 13.1 Global Production, Revenue and Price Forecast by Type (2023-2028)
  • 13.1.1 Global Forecasted Production of Mifepristone API by Type (2023-2028)
  • 13.1.2 Global Forecasted Revenue of Mifepristone API by Type (2023-2028)
  • 13.1.3 Global Forecasted Price of Mifepristone API by Type (2023-2028)
• 13.2 Global Forecasted Consumption of Mifepristone API by Application (2023-2028)
  • 13.2.1 Global Forecasted Production of Mifepristone API by Application (2023-2028)
  • 13.2.2 Global Forecasted Revenue of Mifepristone API by Application (2023-2028)
  • 13.2.3 Global Forecasted Price of Mifepristone API by Application (2023-2028)

14 Research Finding and Conclusion

15 Methodology and Data Source

• 15.1 Methodology/Research Approach
  • 15.1.1 Research Programs/Design
  • 15.1.2 Market Size Estimation
  • 15.1.3 Market Breakdown and Data Triangulation
• 15.2 Data Source
  • 15.2.1 Secondary Sources
  • 15.2.2 Primary Sources
• 15.3 Author List

Summary:

Industry Insights
Due to the COVID-19 pandemic, the global Mifepristone API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥98% accounting for % of the Mifepristone API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Tablet segment is altered to an % CAGR throughout this forecast period.
North America Mifepristone API market is estimated at US$ million in 2021, while Europe is forecast to reach US$ million by 2028. The proportion of the North America is % in 2021, while Europe percentage is %, and it is predicted that Europe share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The global major manufacturers of Mifepristone API include Xianju Pharmaceutical, Junye Pharma, Humanwell Healthcare, KEDE Chemical, Enomark, Richon Chem, Aspen, Formosa Laboratories and Curia Global. etc. In terms of revenue, the global 3 largest players have a % market share of Mifepristone API in 2021.
Key Drivers & Barriers
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2017 to 2028. This section mentions the volume of production by region from 2017 to 2028. Pricing analysis is included in the report according to each type from the year 2017 to 2028, manufacturer from 2017 to 2022, region from 2017 to 2022, and global price from 2017 to 2028.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Post-covid-19 Outlook
The readers in the section will understand how the Mifepristone API market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as production, demand, consumption, supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows production and revenue data by type and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
Purity ≥98%
Purity ≥99%
Segment by Application
Tablet
Capsule
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and production data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and production by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Xianju Pharmaceutical
Junye Pharma
Humanwell Healthcare
KEDE Chemical
Enomark
Richon Chem
Aspen
Formosa Laboratories
Curia Global
Frequently Asked Questions
Which product segment grabbed the largest share in the Mifepristone API market?
How is the competitive scenario of the Mifepristone API market?
Which are the key factors aiding the Mifepristone API market growth?
Which are the prominent players in the Mifepristone API market?
Which region holds the maximum share in the Mifepristone API market?
What will be the CAGR of the Mifepristone API market during the forecast period?
Which application segment emerged as the leading segment in the Mifepristone API market?
What key trends are likely to emerge in the Mifepristone API market in the coming years?
What will be the Mifepristone API market size by 2028?
Which company held the largest share in the Mifepristone API market?